Prevalence of BRCA1 and BRCA2 mutations in unselected breast cancer patients from Peru (Q35217775)

7 August 2017

Prevalence of BRCA1 and BRCA2 mutations in unselected breast cancer patients from Peru (English)

1 reference

7 August 2017

1 reference

15

S A Narod

1 reference

7 August 2017

J Abugattas

1

1 reference

7 August 2017

M Llacuachaqui

2

1 reference

7 August 2017

Y Sullcahuaman Allende

3

1 reference

7 August 2017

A Arias Velásquez

4

1 reference

7 August 2017

R Velarde

5

1 reference

7 August 2017

J Cotrina

6

1 reference

7 August 2017

M Garcés

7

1 reference

7 August 2017

M León

8

1 reference

7 August 2017

G Calderón

9

1 reference

7 August 2017

M de la Cruz

10

1 reference

7 August 2017

P Mora

11

1 reference

7 August 2017

R Royer

12

1 reference

7 August 2017

J Herzog

13

1 reference

7 August 2017

J N Weitzel

14

1 reference

7 August 2017

25 September 2014

1 reference

7 August 2017

1 reference

7 August 2017

88

1 reference

7 August 2017

4

1 reference

7 August 2017

371-375

1 reference

Significant clinical impact of recurrent BRCA1 and BRCA2 mutations in Mexico

7 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4374018

Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4374018

Full-exon pyrosequencing screening of BRCA germline mutations in Mexican women with inherited breast and ovarian cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4374018

Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4374018

Genome-wide association study identifies novel breast cancer susceptibility loci

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4374018

Prevalence of BRCA mutations and founder effect in high-risk Hispanic families

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4374018

BRCA1 and BRCA2: 1994 and beyond

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4374018

Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4374018

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4374018

Breast cancer genetics in African Americans

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4374018

Variation in cancer risks, by mutation position, in BRCA2 mutation carriers

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4374018

Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4374018

The use of preventive measures among healthy women who carry a BRCA1 or BRCA2 mutation

28 July 2018

1 reference

Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial

21 January 2018

1 reference

Reduced mammographic density with use of a gonadotropin-releasing hormone agonist-based chemoprevention regimen in BRCA1 carriers.

21 January 2018

1 reference

BRCA1 and BRCA2 germline mutations in Uruguayan breast and breast-ovarian cancer families. Identification of novel mutations and unclassified variants.

21 January 2018

1 reference

Incidence of BRCA1 and BRCA2 mutations in 54 Chilean families with breast/ovarian cancer, genotype-phenotype correlations.

21 January 2018

1 reference

BRCA1 And BRCA2 analysis of Argentinean breast/ovarian cancer patients selected for age and family history highlights a role for novel mutations of putative south-American origin.

21 January 2018

1 reference

High proportion of BRCA1/2 founder mutations in Hispanic breast/ovarian cancer families from Colombia.

21 January 2018

1 reference

BRCA1 and BRCA2 mutations in breast cancer patients from Venezuela.

21 January 2018

1 reference

BRCA1 and BRCA2 mutations in women of different ethnicities undergoing testing for hereditary breast-ovarian cancer

21 January 2018

1 reference

Prevalence and type of BRCA mutations in Hispanics undergoing genetic cancer risk assessment in the southwestern United States: a report from the Clinical Cancer Genetics Community Research Network

21 January 2018

1 reference

Evidence for common ancestral origin of a recurring BRCA1 genomic rearrangement identified in high-risk Hispanic families

21 January 2018

1 reference

Screening for BRCA1 and BRCA2 mutations in breast cancer patients from Mexico: the public health perspective.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4374018

Spectrum of BRCA1/2 point mutations and genomic rearrangements in high-risk breast/ovarian cancer Chilean families

26 September 2018

1 reference

12 December 2020

Variation in BRCA1 cancer risks by mutation position

1 reference

12 December 2020

Absence of the BRCA1 del (exons 9-12) mutation in breast/ovarian cancer families outside of Mexican Hispanics

1 reference

12 December 2020

A high prevalence of BRCA1 mutations among breast cancer patients from the Bahamas

1 reference

12 December 2020

BRCA1 and BRCA2 mutations in a South American population

1 reference

12 December 2020

Prevalence of BRCA1 and BRCA2 mutations in breast cancer patients from Brazil

1 reference

12 December 2020

MRI surveillance for hereditary breast-cancer risk

1 reference

12 December 2020

Identifiers

DOI

10.1111/CGE.12505

1 reference

7 August 2017

1 reference

7 August 2017

1 reference